for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Basilea Sees No Indication Of Negative Impact On Prescriptions For Cresemba, Zevtera

April 8 (Reuters) - Basilea Pharmaceutica AG:

* BASILEA SHAREHOLDERS APPROVE ALL PROPOSALS OF THE BOARD OF DIRECTORS AT THE ANNUAL GENERAL MEETING

* NO INDICATION FROM ITS COMMERCIAL PARTNERS OF ANY NEGATIVE IMPACT ON PRESCRIPTIONS FOR CRESEMBA AND ZEVTERA

* TOO EARLY TO ASSESS POTENTIAL IMPACT ON BASILEA’S ONGOING CLINICAL STUDIES Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up